NRP1 and cervical cancer: That NRP1 on Tregs plays immunosuppressive role in tumor advancement was documented by a decrease in the number of NRP1+ Tregs in the TDLNs of cervical cancer patients who received preoperative chemotherapy and resulted in favorable outcome, indicating a switch to antitumor immune response activation.